Angiogenesis in Paget's Disease of the Vulva and the Breast: Correlation with Microvessel Density

Patricia E Ellis1, Allan B Maclean, L F Wong Te Fong

  • 1Department of Obstetrics and Gynaecology, Royal Free and University College Medical School (Hampstead Campus), Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.

Insights

Neovascularization, indicated by microvessel density, is key in breast Paget's disease development. However, vulvar Paget's disease pathogenesis involves other biological and molecular factors.

Area of Science:

  • Oncology
  • Pathology
  • Gynecologic Oncology

Background:

  • The pathogenesis of Paget's disease of the vulva and breast is not fully understood.
  • Angiogenesis, the formation of new blood vessels, is implicated in various disease processes.
  • Investigating angiogenesis via microvessel density may elucidate Paget's disease mechanisms.

Purpose of the Study:

  • To determine the role of angiogenesis, assessed by microvessel density, in the pathogenesis of vulvar and breast Paget's disease.
  • To compare microvessel density in different subtypes of breast and vulvar Paget's disease.

Main Methods:

  • Analysis of microvessel density using anti-von Willebrand factor antibody.
  • Study included 105 cases: 71 vulvar Paget's disease (8 with invasive disease) and 34 breast Paget's disease.
  • Breast cases included ductal carcinoma in situ (DCIS), invasive carcinoma, or no identified tumor.

Main Results:

  • Increased microvessel density was observed in breast Paget's disease with DCIS (P < 0.08) and carcinoma alone (P < 0.013) compared to breast Paget's disease alone.
  • No significant differences in microvessel density were found in the vulvar Paget's disease cases.
  • Neovascularization appears crucial for breast Paget's disease progression.

Conclusions:

  • Neovascularization plays a significant role in the development of breast Paget's disease.
  • Pathogenesis of vulvar Paget's disease likely involves different biological and molecular mechanisms beyond angiogenesis.
  • Further research into these distinct pathways is warranted for targeted therapies.